Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHKU4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,997
Award facts
- Contract value 100% obligated
- $11,996.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,996.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 100-unit vials of BOTOX. The delivery order, issued on January 5, 2026, with an ultimate completion date of January 27, 2026, carries no set-aside designation, indicating the contractor won through open competition. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to streamline pharmaceutical supply chains across the Department of Defense.
As a single-award prime vendor contractor under the PPV-G GEN V initiative, DMS Pharmaceutical Group is authorized to supply a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to military healthcare facilities worldwide. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, positions the company as a critical supplier for Department of Defense healthcare operations. This delivery order represents one of numerous purchase orders issued to the contractor by the Defense Logistics Agency's Medical Supply Chain division, reflecting its demonstrated capability to meet the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHKU4?
SPE2DR26FHKU4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FHKU4 worth?
The government has obligated $11,997 on SPE2DR26FHKU4.
Is contract SPE2DR26FHKU4 an order under another contract?
Yes. SPE2DR26FHKU4 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKU4 competed?
The extent of competition for SPE2DR26FHKU4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award